Wei-Xing Guo

Title: Innovations by Wei-Xing Guo in Proliferative Disease Research

Introduction

Wei-Xing Guo is an accomplished inventor based in Northridge, CA. He has made significant contributions to the field of medical research, particularly in the area of proliferative diseases. With a total of 2 patents, his work focuses on innovative methods for screening and treating these diseases.

Latest Patents

Wei-Xing Guo's latest patents include groundbreaking methods of screening for the risk of proliferative diseases. One of his notable inventions involves detecting the presence or absence of upregulation of the CLN3 gene in subjects. This upregulation indicates an increased risk of developing a proliferative disease. Additionally, his patents disclose methods for screening compounds aimed at treating proliferative diseases based on the CLN3 gene and its product. These methods also encompass treatment strategies and vectors that are useful in combating such diseases.

Career Highlights

Wei-Xing Guo is affiliated with Duke University, where he continues to advance his research in the medical field. His work has garnered attention for its potential impact on understanding and treating proliferative diseases.

Collaborations

Some of his notable coworkers include Andrea Amalfitano and Rose-Mary N Boustany. Their collaborative efforts contribute to the innovative research environment at Duke University.

Conclusion

Wei-Xing Guo's contributions to the field of proliferative disease research through his patents and collaborations highlight his role as a significant inventor. His innovative methods have the potential to improve screening and treatment options for patients at risk of these diseases.